OCM
CPRX

One Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History

One Capital Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.35M Hold
94,731
– – 0.07% 197
2026
Q1 		$2.35M Buy
94,731
+19,758
+26% +$471K 0.06% 197
2025
Q4 		$1.75M Buy
74,973
+28,433
+61% +$633K 0.05% 225
2025
Q3 		$917K Buy
46,540
+19,751
+74% +$406K 0.03% 286
2025
Q2 		$581K Buy
+26,789
New +$632K 0.02% 348

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

One Capital Management's CPRX Position: Q2 2026 in Review

One Capital Management held its Catalyst Pharmaceutical (CPRX) position steady in Q2 2026 at 94,731 shares worth $2.35M. The position accounts for 0.07% of the portfolio, ranked #197.

One Capital Management first reported a position in CPRX in Q2 2025 and has held it in 5 quarters since. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • One Capital Management held 94,731 shares of Catalyst Pharmaceutical worth $2.35M as of Q2 2026.
  • One Capital Management left its Catalyst Pharmaceutical share count unchanged in Q2 2026.
  • Catalyst Pharmaceutical made up 0.07% of One Capital Management's portfolio in Q2 2026, its #197 holding.
  • One Capital Management first reported a position in Catalyst Pharmaceutical in Q2 2025 and has held it in 5 quarters since.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on One Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.